Concepedia
Statistics
Publications
4
Citations
1.8K
H-Index
Active since
2011
Affiliations
Virginia Commonwealth University(Current)
Intercept Pharmaceuticals (United States)
University of Gothenburg
FGK Clinical Research
University of Alberta
Cathi Sciacca is an author at Virginia Commonwealth University specializing in pharmacology, pharmacotherapy, and hepatology.
Publications per year
2011–2017
Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Sunder Mudaliar, Robert R. Henry, Arun J. Sanyal et al. · Gastroenterology · 2013 · 915 citations
Medicine, Endocrinology, Pharmacology +12
Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
Gideon M. Hirschfield, Andrew L. Mason, Velimir A. Luketic et al. · Gastroenterology · 2014 · 565 citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +15
A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis
Kris V. Kowdley, Velimir A. Luketic, Roger W. Chapman et al. · Hepatology · 2017 · 277 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +16
28 AN INTERNATIONAL STUDY EVALUATING THE FARNESOID X RECEPTOR AGONIST OBETICHOLIC ACID AS MONOTHERAPY IN PBC
Kris V. Kowdley, David Jones, Velimir A. Luketic et al. · Journal of Hepatology · 2011 · 63 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +4
1–4 of 4